Enrique A Conterno - Net Worth and Insider Trading
Enrique A Conterno Net Worth
The estimated net worth of Enrique A Conterno is at least $110 Million dollars as of 2024-12-27. Enrique A Conterno is the SVP&Pres, LillyDiab & LillyUSA of Eli Lilly and Co and owns about 138,121 shares of Eli Lilly and Co (LLY) stock worth over $110 Million. Enrique A Conterno is also the CEO of FibroGen Inc and owns about 402,522 shares of FibroGen Inc (FGEN) stock worth over $233,060. Details can be seen in Enrique A Conterno's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Enrique A Conterno has not made any transactions after 2023-07-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Enrique A Conterno
Enrique A Conterno Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Enrique A Conterno owns 2 companies in total, including FibroGen Inc (FGEN) , and Eli Lilly and Co (LLY) .
Click here to see the complete history of Enrique A Conterno’s form 4 insider trades.
Insider Ownership Summary of Enrique A Conterno
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FGEN | FibroGen Inc | 2023-07-07 | director & Chief Executive Officer |
| LLY | Eli Lilly and Co | 2019-02-15 | Sr. VP & Pres. & Lilly Diabetes |
Enrique A Conterno Latest Holdings Summary
Enrique A Conterno currently owns a total of 2 stocks. Among these stocks, Enrique A Conterno owns 138,121 shares of Eli Lilly and Co (LLY) as of February 15, 2019, with a value of $110 Million and a weighting of 99.79%. Enrique A Conterno also owns 402,522 shares of FibroGen Inc (FGEN) as of July 7, 2023, with a value of $233,060 and a weighting of 0.21%.
Latest Holdings of Enrique A Conterno
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2019-02-15 | 138,121 | 794.14 | 109,687,411 |
| FGEN | FibroGen Inc | 2023-07-07 | 402,522 | 0.58 | 233,060 |
Holding Weightings of Enrique A Conterno
Enrique A Conterno Form 4 Trading Tracker
According to the SEC Form 4 filings, Enrique A Conterno has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 25,000 shares on February 15, 2019, which brought Enrique A Conterno around $3 Million.
According to the SEC Form 4 filings, Enrique A Conterno has made a total of 8 transactions in FibroGen Inc (FGEN) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in FibroGen Inc is the sale of 1,880 shares on July 7, 2023, which brought Enrique A Conterno around $5,264.
Insider Trading History of Enrique A Conterno
- 1
Enrique A Conterno Trading Performance
GuruFocus tracks the stock performance after each of Enrique A Conterno's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Enrique A Conterno is 20.49%. GuruFocus also compares Enrique A Conterno's trading performance to market benchmark return within the same time period. The performance of stocks bought by Enrique A Conterno within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Enrique A Conterno's insider trading performs compared to the benchmark.
Performance of Enrique A Conterno
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.34 | | | | | |
| Relative Return to S&P 500(%) | 13.25 | | | | | |
Enrique A Conterno Ownership Network
Enrique A Conterno Owned Company Details
What does FibroGen Inc do?
Who are the key executives at FibroGen Inc?
Enrique A Conterno is the director & Chief Executive Officer of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , SVP & China Operations Christine Chung , and Chief Financial Officer Juan Graham .
FibroGen Inc (FGEN) Insider Trades Summary
Over the past 18 months, Enrique A Conterno made 1 insider transaction in FibroGen Inc (FGEN) with a net sale of 1,880. Other recent insider transactions involving FibroGen Inc (FGEN) include a net sale of 6,000 shares made by Jeffrey William Henderson , a net purchase of 50,000 shares made by Thane Wettig , and a net purchase of 22,123 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,880 shares of FibroGen Inc (FGEN) were sold and 72,123 shares were bought by its insiders, resulting in a net purchase of 64,243 shares.
FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
FibroGen Inc Insider Transactions
Enrique A Conterno Mailing Address
Above is the net worth, insider trading, and ownership report for Enrique A Conterno. You might contact Enrique A Conterno via mailing address: Lilly Corporate Center, Indianapolis In 46285.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
